ERAS Scorecard | Erasca, Inc.

Erasca, Inc. (ERAS) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

11/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	LoseERAS / S&P 13.23% / 15.20%	LoseERAS / S&P ERAS unavailable / 15.00%	WinERAS / S&P 120.93% / 50.40%
2026-Q12/3	WinERAS / S&P 334.95% / -4.33%	LoseERAS / S&P ERAS unavailable / 11.30%	WinERAS / S&P 55.00% / 27.70%
2025-Q41/3	WinERAS / S&P 70.64% / 2.65%	LoseERAS / S&P ERAS unavailable / 9.00%	LoseERAS / S&P -38.89% / 13.40%
2025-Q31/3	WinERAS / S&P 71.65% / 8.12%	LoseERAS / S&P ERAS unavailable / 4.61%	LoseERAS / S&P -47.56% / 13.45%
2025-Q20/3	LoseERAS / S&P -7.30% / 10.94%	LoseERAS / S&P ERAS unavailable / 4.83%	LoseERAS / S&P -52.75% / 10.63%
2025-Q10/3	LoseERAS / S&P -45.42% / -4.27%	LoseERAS / S&P ERAS unavailable / 4.98%	LoseERAS / S&P -27.71% / 10.57%
2024-Q40/3	LoseERAS / S&P -8.06% / 2.41%	LoseERAS / S&P ERAS unavailable / 5.25%	LoseERAS / S&P -12.20% / 6.15%
2024-Q31/3	WinERAS / S&P 15.68% / 5.89%	LoseERAS / S&P ERAS unavailable / 5.89%	LoseERAS / S&P -52.33% / 6.11%
2024-Q21/3	WinERAS / S&P 14.56% / 4.28%	LoseERAS / S&P ERAS unavailable / 5.38%	LoseERAS / S&P -49.72% / 5.12%
2024-Q10/3	LoseERAS / S&P -3.29% / 10.56%	LoseERAS / S&P ERAS unavailable / 5.71%	LoseERAS / S&P -56.32% / 5.59%
2023-Q40/3	LoseERAS / S&P 8.12% / 11.69%	LoseERAS / S&P ERAS unavailable / 6.81%	LoseERAS / S&P -58.79% / 7.78%
2023-Q31/3	LoseERAS / S&P -28.62% / -3.27%	LoseERAS / S&P ERAS unavailable / 7.52%	WinERAS / S&P 102.35% / -5.03%
2023-Q21/3	LoseERAS / S&P -8.31% / 8.74%	LoseERAS / S&P ERAS unavailable / 9.50%	WinERAS / S&P 77.45% / -8.57%
2023-Q11/3	LoseERAS / S&P -30.16% / 7.50%	LoseERAS / S&P ERAS unavailable / 10.77%	WinERAS / S&P -1.04% / -15.69%
2022-Q40/3	LoseERAS / S&P -44.74% / 7.56%	LoseERAS / S&P ERAS unavailable / 11.88%	LoseERAS / S&P ERAS unavailable / -17.99%
2022-Q31/3	WinERAS / S&P 40.04% / -4.88%	LoseERAS / S&P ERAS unavailable / 13.47%	LoseERAS / S&P ERAS unavailable / -1.41%
2022-Q20/3	LoseERAS / S&P -35.23% / -16.10%	LoseERAS / S&P ERAS unavailable / 13.71%	LoseERAS / S&P ERAS unavailable / 11.04%
2022-Q10/3	LoseERAS / S&P -44.80% / -4.60%	LoseERAS / S&P ERAS unavailable / 15.97%	LoseERAS / S&P ERAS unavailable / 42.23%
2021-Q40/3	LoseERAS / S&P -26.58% / 11.03%	LoseERAS / S&P ERAS unavailable / 15.00%	LoseERAS / S&P ERAS unavailable / 96.40%
2021-Q30/3	LoseERAS / S&P ERAS unavailable / 0.58%	LoseERAS / S&P ERAS unavailable / 10.77%	LoseERAS / S&P ERAS unavailable / 69.42%
2021-Q20/3	LoseERAS / S&P ERAS unavailable / 8.55%	LoseERAS / S&P ERAS unavailable / 6.58%	LoseERAS / S&P ERAS unavailable / 51.81%
2021-Q10/3	LoseERAS / S&P ERAS unavailable / 6.17%	LoseERAS / S&P ERAS unavailable / -1.06%	LoseERAS / S&P ERAS unavailable / 7.39%
2020-Q40/3	LoseERAS / S&P ERAS unavailable / 12.15%	LoseERAS / S&P ERAS unavailable / -3.72%	LoseERAS / S&P ERAS unavailable / -33.42%
2020-Q30/3	LoseERAS / S&P ERAS unavailable / 8.93%	LoseERAS / S&P ERAS unavailable / -2.04%	LoseERAS / S&P ERAS unavailable / -27.10%
2020-Q20/3	LoseERAS / S&P ERAS unavailable / 20.54%	LoseERAS / S&P ERAS unavailable / -0.46%	LoseERAS / S&P ERAS unavailable / -27.11%
2020-Q10/3	LoseERAS / S&P ERAS unavailable / -19.60%	LoseERAS / S&P ERAS unavailable / 3.47%	LoseERAS / S&P ERAS unavailable / -14.75%
2019-Q40/3	LoseERAS / S&P ERAS unavailable / 9.07%	LoseERAS / S&P ERAS unavailable / 5.36%	LoseERAS / S&P ERAS unavailable / 2.99%
2019-Q30/3	LoseERAS / S&P ERAS unavailable / 1.70%	LoseERAS / S&P ERAS unavailable / 5.02%	LoseERAS / S&P ERAS unavailable / 0.21%
2019-Q20/3	LoseERAS / S&P ERAS unavailable / 4.30%	LoseERAS / S&P ERAS unavailable / 6.64%	LoseERAS / S&P ERAS unavailable / 8.65%
2019-Q10/3	LoseERAS / S&P ERAS unavailable / 13.65%	LoseERAS / S&P ERAS unavailable / 8.12%	LoseERAS / S&P ERAS unavailable / 14.29%
2018-Q40/3	LoseERAS / S&P ERAS unavailable / -13.52%	LoseERAS / S&P ERAS unavailable / 9.05%	LoseERAS / S&P ERAS unavailable / 18.23%
2018-Q30/3	LoseERAS / S&P ERAS unavailable / 7.71%	LoseERAS / S&P ERAS unavailable / 10.21%	LoseERAS / S&P ERAS unavailable / 19.06%
2018-Q20/3	LoseERAS / S&P ERAS unavailable / 3.43%	LoseERAS / S&P ERAS unavailable / 9.03%	LoseERAS / S&P ERAS unavailable / 14.46%
2018-Q10/3	LoseERAS / S&P ERAS unavailable / -0.76%	LoseERAS / S&P ERAS unavailable / 7.68%	LoseERAS / S&P ERAS unavailable / 12.46%
2017-Q40/3	LoseERAS / S&P ERAS unavailable / 6.64%	LoseERAS / S&P ERAS unavailable / 7.03%	LoseERAS / S&P ERAS unavailable / 13.82%
2017-Q30/3	LoseERAS / S&P ERAS unavailable / 4.48%	LoseERAS / S&P ERAS unavailable / 5.68%	LoseERAS / S&P ERAS unavailable / 17.57%
2017-Q20/3	LoseERAS / S&P ERAS unavailable / 3.09%	LoseERAS / S&P ERAS unavailable / 4.83%	LoseERAS / S&P ERAS unavailable / 17.74%
2017-Q10/3	LoseERAS / S&P ERAS unavailable / 6.07%	LoseERAS / S&P ERAS unavailable / 3.67%	LoseERAS / S&P ERAS unavailable / 13.32%
2016-Q40/3	LoseERAS / S&P ERAS unavailable / 3.82%	LoseERAS / S&P ERAS unavailable / 2.09%	LoseERAS / S&P ERAS unavailable / 7.05%
2016-Q30/3	LoseERAS / S&P ERAS unavailable / 3.85%	LoseERAS / S&P ERAS unavailable / 0.20%	LoseERAS / S&P ERAS unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	ERAS total return	S&P 500 Total Return Index
Total return	1141.40%	20.78%
Annualized return	1141.40%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	ERAS total return	S&P 500 Total Return Index
Total return	-14.74%	83.14%
Annualized return	-3.14%	12.86%

10Y · 2021-07-16 to 2026-08-27

Metric	ERAS total return	S&P 500 Total Return Index
Total return	11.82%	319.30%
Annualized return	1.12%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Veradermics, Inc (MANE)	United States	$4.839B
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
Edgewise Therapeutics, Inc. (EWTX)	United States	$4.470B	-22.23
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Viking Therapeutics, Inc. (VKTX)	United States	$4.287B	-8.51